Thrombotic microangiopathies: An update

Hematology

Volumn 11, Issue 3, 2006, Pages 139-146

  Franchini, Massimo ^a  

^a Ospedaliera di Verona   (Italy)

Author keywords

Escherichia coli; Hemolytic uremic syndrome; Thrombotic microangiopathies; Thrombotic thrombocytopenic purpura

Indexed keywords

ANTIBIOTIC AGENT; ANTITHROMBOCYTIC AGENT; AZATHIOPRINE; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; CARBOPLATIN; CISPLATIN; CLOPIDOGREL; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ESCHERICHIA COLI VACCINE; FIBRINOGEN RECEPTOR; GLUCOCORTICOID; GLYCOPROTEIN IB ALPHA; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; LACTATE DEHYDROGENASE; MEMBRANE COFACTOR PROTEIN; MITOMYCIN C; PENICILLIN G; QUININE; RIFAMPICIN; RITUXIMAB; TACROLIMUS; THROMBOPLASTIN; TICLOPIDINE; VINCRISTINE; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

CLINICAL FEATURE; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DRUG MECHANISM; DRUG MEGADOSE; ENZYME ACTIVITY; FEVER; HEMODIALYSIS; HEMOLYTIC ANEMIA; HEMOLYTIC UREMIC SYNDROME; HUMAN; KIDNEY FAILURE; PATHOPHYSIOLOGY; PLASMA TRANSFUSION; PLASMAPHERESIS; PRIORITY JOURNAL; PURPURA; REVIEW; SPLENECTOMY; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; THROMBOGENESIS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADAM PROTEINS; ADULT; CASE MANAGEMENT; CHILD; ESCHERICHIA COLI INFECTIONS; HEMOLYTIC-UREMIC SYNDROME; HUMANS; PLASMA EXCHANGE; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RECOMBINANT PROTEINS;

EID: 33748499609     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330600667583     Document Type: Review

References (133)

1. Symmers, W. (1952) Thrombotic microangiopathic hemolytic anemia (thrombotic micorangiopathy) Br Med J, 2, pp. 897-903.
2. Nabhan, C and Kwaan, HC. (2003) Current concepts in the diagnosis and management of thrombotic thrombocytopenic purpura Hematol Oncol Clin North Am, 7, pp. 177-199.
3. Moschcowitz, E. (1924) Hyaline thrombosis of the terminal arterioles and capillaries: A hitherto undescribed disease Proc N Y Pathol Soc, 24, pp. 21-24.
4. Moake, JL. (2002) Thrombotic microangiopathies N Engl J Med, 347, pp. 589-600.
5. Gasser, C and Gautier, E and Steek, A and Siebenmann, RE and Oechslin, R. (1955) Hämolytisch-uramische syndrome: Bilaterale Nierenrindennekrosen bei akuten eroworbenen hämolytischen Anas̈mien Schweiz Med Wochenschr, 85, pp. 905-909.
6. Furlan, M and Lämmle, B. (2000) Haemolytic-uraemic syndrome and thrombotic thrombocytopenic purpura - new insights into underlying biochemical mechanisms Nephrol Dial Transplant, 15, pp. 1112-1114.
7. Amorosi, EL and Ultmann, JE. (1966) Thrombotic thrombocytopenic purpura: Report of 16 cases and review of the literature Medicine (Baltimore), 45, pp. 139-159.
8. Cuttner, J. (1980) Thrombotic thrombocytopenic purpura: A ten-year experience Blood, 56(302), pp. 306.
9. Petitt, RM. (1980) Thrombotic thrombocytopenic purpura: A thirty-year review Semin Thromb Hemost, 6, pp. 350-355.
10. Ridolfi, RL and Bell, WR. (1981) Thrombotic thrombocytopenic purpura. Report of 25 cases and review of the literature Medicine (Baltimore), 60, pp. 413-428.
11. Kwaan, HC. (1987) Clinicopathologic features of thrombotic thrombocytopenic purpura Semin Hematol, 24, pp. 71-81.
12. Sagripanti, A and Carpi, A and Baicchi, U and (1996) Plasmatic parameters of coagulation activation in thrombotic microangiopathy Biomed Pharmacother, 50, pp. 357-362.
13. Allford, SL and Hunt, BJ and Rose, P and Machin, SJ. (2003) Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias Br J Haematol, 120, pp. 556-573. on behalf of the Thrombosis Task Force of the British Committee for Standards in Haematology
14. Bell, WR and Braine, HG and Ness, PM and Kickler, TS. (1991) Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients N Engl J Med, 325, pp. 398-403.
15. Moake, JL and Rudy, CK and Troll, JH and (1982) Unusually large plasma factor VIII: Von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura N Engl J Med, 307, pp. 1432-1435.
16. Furlan, M and Robles, R and Solenthaler, M and Wassmer, M and Sandoz, P and Lämmle, B. (1997) Deficient activity of von Willebrand factor cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura Blood, 89, pp. 3097-3103.
17. Moake, JL. (1994) Haemolytic-uraemic syndrome: Basic science Lancet, 343, pp. 393-397.
18. Kaplan, BS and Proesmans, W. (1987) Hemolytic uremic syndrome of childhood and its variants Semin Hematol, 24, pp. 148-160.
19. Karmali, MA and Petric, M and Lim, C and Fleming, PC and Arbus, GS and Lior, H. (1985) The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli J Infect Dis, 151, pp. 775-782.
20. Rondeau, E and Peraldi, M-N. (1996) Escherichia coli and hemolytic uremic syndrome N Engl J Med, 335, pp. 660-662.
21. Drummond, KN. (1985) Hemolytic uremic syndrome - then and now N Engl J Med, 312, pp. 116-118.
22. Cimolai, N and Carter, JE and Morrison, BJ and Anderson, JD. (1990) Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndrome J Pediatr, 116, pp. 589-592.
23. Griffin, PM and Olmstead, LC and Petras, RE. (1990) Escherichia coli 0157:H7-associated colitis. A clinical and histological study of 11 cases Gastroenterology, 99, pp. 142-149.
24. Griffin, PM and Ostroff, SM and Tauxe, RV and (1988) Illnesses associated with Escherichia coli 0157:H7 infections. A broad clinical spectrum Ann Intern Med, 109, pp. 705-712.
25. Keusch, GT and Acheson, DW. (1997) Thrombotic thrombocytopenic purpura associated with shiga toxins Semin Hematol, 34, pp. 106-116.
26. Raife, T and Montgomery, R. (2001) New aspects in the pathogenesis and treatment of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome Rev Clin Exp Hematol, 5, pp. 236-261.
27. Chandler, WL and Jelacic, S and Boster, DR and (2002) Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome N Engl J Med, 346, pp. 23-32.
28. Warwicker, P and Donne, RL and Goodship, JA and (1999) Familial relapsing haemolytic uraemic syndrome and complement factor H deficiency Nephrol Dial Transplant, 14, pp. 1229-1233.
29. Warwicker, P and Goodship, JA and Goodship, TH. (1998) Factor H - US? Nephrol Dial Transplant, 13, pp. 1921-1923.
30. Warwicker, P and Goodship, TH and Donne, RL and (1998) Genetic studies into inherited and sporadic hemolytic uremic syndrome Kidney Int, 53, pp. 836-844.
31. Stratton, JD and Warwicker, P. (2002) Successful treatment of factor H-related haemolytic uraemic syndrome Nephrol Dial Transplant, 17, pp. 684-685.
32. Noris, M and Brioschi, S and Caprioli, J and (2003) Familial haemolytic uraemic syndrome and an MCP mutation Lancet, 362, pp. 1542-1547. International Registry of Recurrent and Familial HUS/TTP
33. Vipan, VH. (1865) Quinine as a cause of purpura Lancet, 2, pp. 37.
34. Gordon, LI and Kwaan, HC. (1997) Cancer- and drug-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome Semin Hematol, 34, pp. 140-147.
35. Van Buren, D and Van Buren, CT and Flechner, SM and Maddox, AM and Verani, R and Kahan, BD. (1985) De novo hemolytic uremic syndrome in renal transplant recipients immunosuppressed with cyclosporine Surgery, 98(54), pp. 62.
36. Dzik, WH and Georgi, BA and Khettry, U and Jenkins, RL. (1987) Cyclosporine-associated thrombotic thrombocytopenic purpura following liver transplantation - successful treatment with plasma exchange Transplantation, 44, pp. 570-572.
37. Holler, E and Kolb, HJ and Hiller, E and (1989) Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA- identical bone marrow transplantation Blood, 73, pp. 2018-2024.
38. Dhib, M and Moulin, B and Abderrahim, E and Etienne, I and Godin, M and Fillastre, JP. (1993) Cyclosporine-associated thrombotic microangiopathy: Report of two cases with good outcome and successful subsequent reuse Transplant Proc, 25, pp. 2294-2296.
39. Holman, MJ and Gonwa, TA and Cooper, B and (1993) FK506-associated thrombotic thrombocytopenic purpura Transplantation, 55, pp. 205-206.
40. Maguire, RB and Stroncek, DF and Campbell, AC. (1993) Recurrent pancytopenia, coagulopathy, and renal failure associated with multiple quinine-dependent antibodies Ann Int Med, 119, pp. 215-217.
41. Knower, MT and Bowton, DL and Owen, J and Dunagan, DP. (2003) Quinine-induced disseminated intravascular coagulation: Case report and review of the literature Intensive Care Med, 29, pp. 1007-1011.
42. Parker, C and Barnett, D. (1976) Microangiopathic hemolysis and thrombocytopenia related to penicillin drug Arch Int Med, 126, pp. 474-477.
43. Fahal, IH and Williams, PS and Clark, RE and Bell, GM. (1992) Thrombotic thrombocytopenic purpura due to rifampicin Br Med J, 304, pp. 882.
44. Rabadi, SJ and Khandekar, JD and Miller, HJ. (1982) Mitomycin-induced hemolytic uremic syndrome: Case presentation and review of the literature Cancer Treatment Rep, 66, pp. 1244-1247.
45. Byrnes, JJ and Baquerizo, H and Gonzalez, M and Hensely, GT. (1986) Thrombotic thrombocytopenic purpura subsequent to acute myelogenous leukemia chemotherapy Am J Hematol, 21(299), pp. 304.
46. Jackson, AM and Rose, BD and Graff, LG and (1984) Thrombotic microangiopathy and renal failure associated with antineoplastic chemotherapy Ann Int Med, 101, pp. 41-44.
47. Fisher, DC and Sherrill, GB and Hussein, A and (1996) Thrombotic microangiopathy as a complication of high-dose chemotherapy for breast cancer Bone Marrow Transplant, 18, pp. 193-198.
48. Page, Y and Tardy, B and Zeni, F and Comtet, C and Terrana, R and Bertrand, JC. (1991) Thrombotic thrombocytopenic purpura related to ticlopidine Lancet, 337, pp. 774-776.
49. Kovacs, MJ and Soong, PY and Chin-Yee, IH. (1993) Thrombotic thrombocytopenic purpura associated with ticlopidine Ann Pharmacother, 27, pp. 1060-1061.
50. Bennett, CL and Kiss, JE and Weinberg, PD and (1998) Thrombotic thrombocytopenic purpura after stenting and ticlopidine Lancet, 352, pp. 1036-1037.
51. Bennett, CL and Weinberg, PD and Rozenberg-Ben-Dror, K and Yarnold, PR and Kwaan, HC and Green, D. (1998) Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases Ann Int Med, 128, pp. 541-544.
52. Bennett, CL and Connors, JM and Carwile, JM and (2000) Thrombotic thrombocytopenic purpura associated with clopidogrel N Engl J Med, 342, pp. 1773-1777.
53. Walker, RW and Rosemblum, MK and Kempin, SJ and Christian, MC. (1989) Carboplatin-associated thrombotic microangiopathic hemolytic anemia Cancer, 64, pp. 1017-1020.
54. Murgo, AJ. (1987) Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents Semin Hematol, 24, pp. 161-177.
55. Chang, JC and Naqvi, T. (2003) Thrombotic thrombocytopenic purpura associated with bone marrow metastasis and secondary myelofibrosis in cancer Oncologist, 8, pp. 375-380.
56. George, JN and Li, X and McMinn, JR and Terrell, DR and Vesely, SK and Selby, GB. (2004) Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: A diagnostic dilemma Transfusion, 44, pp. 294-304.
57. Schriber, JR and Herzig, GP. (1997) Transplantation-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome Semin Hematol, 34, pp. 126-133.
58. McCrae, KR and Cines, DB. (1997) Thrombotic microangiopathy during pregnancy Semin Hematol, 34, pp. 148-158.
59. Ezra, Y and Rose, M and Eldor, A. (1996) Therapy and prevention of thrombotic thrombocytopenic purpura during pregnancy: A clinical study of 16 pregnancies Am J Hematol, 51, pp. 1-6.
60. Weiner, CP. (1987) Thrombotic microangiopathy in pregnancy and the postpartum period Semin Hematol, 24, pp. 119-129.
61. Proia, A and Paesano, R and Torcia, F and (2002) Thrombotic thrombocytopenic purpura and pregnancy: A case report and review of the literature Ann Hematol, 81, pp. 210-214.
62. Leaf, AN and Laubenstein, LJ and Raphael, B and Hochster, H and Baez, L and Karpatkin, S. (1988) Thrombotic thrombocytopenic purpura associated with human immunodeficiency virus type 1 (HIV-1) infection Ann Int Med, 109, pp. 194-197.
63. Hymes, KB and Karpatkin, S. (1997) Human immunodeficiency virus infection and thrombotic microangiopathy Semin Hematol, 34, pp. 117-125.
64. Meisenberg, BR and Robinson, WL and Mosley, CA and Duke, MS and Rabetoy, GM and Kosty, MP. (1988) Thrombotic thrombocytopenic purpura in human immunodeficiency (HIV) - seropositive males Am J Hematol, 27, pp. 212-215.
65. Rarick, MU and Espina, B and Mocharnuk, R and Trilling, Y and Levine, AM. (1992) Thrombotic thrombocytopenic purpura in patients with human immunodeficiency virus infection: A report of three cases and review of the literature Am J Hematol, 40, pp. 103-109.
66. Ahmed, S and Siddiqui, RK and Siddiqui, AK and Zaidi, SA and Cervia, J. (2002) HIV associated thrombotic microangiopathy Postgrad Med J, 78, pp. 520-525.
67. Jorfen, M and Callejas, JL and Formiga, F and Cervera, R and Font, J and Ingelmo, M. (1998) Fulminant thrombotic thrombocytopenic purpura in systemic lupus erythematosus Scand J Rheumatol, 27, pp. 76-77.
68. Miller, A and Ryan, PF and Dowling, JP. (1997) Vasculitis and thrombotic thrombocytopenic purpura in a patient with limited scleroderma J Rheumatol, 24, pp. 598-600.
69. Espinosa, G and Bucciarelli, S and Cervera, R and (2004) Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies Ann Rheumatol Dis, 63, pp. 730-736.
70. Moake, JL. (1998) Moschcowitz, multimers, and metalloprotease N Engl J Med, 339(1629), pp. 1631.
71. Tsai, HM. (2004) Molecular mechanisms in thrombotic thrombocytopenic purpura Semin Thromb Haemost, 30, pp. 549-557.
72. Soejima, K and Nakagaki, T. (2005) Interplay between ADAMTS13 and von Willebrand factor in inherited and acquired thrombotic microangiopathies Semin Hematol, 42, pp. 56-62.
73. Nishio, K and Anderson, PJ and Zheng, XL and Sadler, JE. (2004) Binding of platelet glycoprotein Ibalpha to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13 Proc Natl Acad Sci USA, 101, pp. 10578-10583.
74. Crawley, JT and Lam, JK and Rance, JB and Mollica, LR and O'Donnell, JS and Lane, DA. (2005) Proteolytic inactivation of ADAMTS13 by thrombin and plasmin Blood, 105, pp. 1085-1093.
75. Furlan, M and Robles, R and Lämmle, B. (1996) Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis Blood, 87, pp. 4223-4234.
76. Tsai, HM. (1996) Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion Blood, 87, pp. 4235-4244.
77. Furlan, M and Robles, R and Solenthaler, M and Lämmle, B. (1998) Acquired deficiency of von Willebrand factor cleaving protease in a patient with thrombotic thrombocytopenic purpura Blood., 91, pp. 2839-2846.
78. Tsai, HM and Lian, EC. (1998) Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura N Engl J Med, 339, pp. 1585-1594.
79. Furlan, M and Robles, R and Galbusera, M and (1998) von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome N Engl J Med, 339, pp. 1578-1584.
80. Veyradier, A and Obert, B and Houllier, A and Meyer, D and Girma, JP. (2001) Specific von Willebrand factor-cleaving protease in thrombotic microangiopathy: A study of 111 cases Blood, 98, pp. 1765-1772.
81. Fujikawa, K and Suzuki, H and McMullen, B and Chung, D. (2001) Purification of human von Willebrand factor cleaving protease and its identification as a new member of the metalloproteinase family Blood, 98, pp. 1662-1666.
82. Gerritsen, HE and Robles, R and Lämmle, B and Furlan, M. (2001) Partial amino acid sequence of purified von Willebrand factor-cleaving protease Blood, 98, pp. 1654-1661.
83. Zheng, X and Chung, D and Takayama, TK and Majerus, EM and Sadler, JE and Fujikawa, K. (2001) Structure of von Willebrand factor cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura J Biol Chem, 276, pp. 41059-41063.
84. Levy, GG and Nichols, WC and Lian, EC and (2001) Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura Nature, 413, pp. 488-494.
85. Kokame, K and Miyata, T. (2004) Genetic defects leading to hereditary thrombotic thrombocytopenic purpura Semin Hematol, 41, pp. 34-40.
86. Lindberg, AA and Brown, JE and Stromberg, N and Westling-Ryd, M and Schultz, JE and Karlsson, KA. (1987) Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1 J Biol Chem, 262, pp. 1779-1785.
87. Ruggenenti, P and Noris, M and Remuzzi, G. (2001) Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura Kidney Int, 60, pp. 831-846.
88. Pruimboom-Brees, IM and Morgan, TW and Ackermann, MR and (2000) Cattle lack vascular receptors for Escherichia coli O157:H7 Shiga toxins Proc Nat Acad Sci USA, 97, pp. 10325-10329.
89. Kiyokawa, N and Taguchi, T and Mori, T and (1998) Induction of apoptosis in normal human renal tubular epithelial cells by Escherichia coli Shiga toxins 1 and 2 J Infect Dis, 178, pp. 178-184.
90. Ray, PE and Liu, XH. (2001) Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome Pediatr Nephrol 16, pp. 823-839.
91. Hughes, AK and Stricklett, PK and Kohan, DE. (2001) Shiga toxin-1 regulation of cytokine production by human glomerular epithelial cells Nephron, 88, pp. 14-23.
92. Morigi, M and Galbusera, M and Binda, E and Imberti, B and Gastoldi, S and Remuzzi, A. (2001) Verotoxin-1-induced up-regulation of adhesive molecules renders microvascular endothelial cells thrombogenic at high shear stress Blood, 98, pp. 1828-1835.
93. Karpman, D and Papadopoulou, D and Nilsson, K and Sjogren, AC and Mikaelsson, C and Lethagen, S. (2001) Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndrome Blood, 97, pp. 3100-3108.
94. Wolf, G. (2004) Not known from ADAM(TS-13) - novel insights into the pathophysiology of thrombotic microangiopathies Nephrol Dial Transplant, 19, pp. 1687-1693.
95. Tsai, HM and Chandler, WL and Sarode, R and (2001) von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7-associated hemolytic uremic syndrome Pediatr Res 49, pp. 653-659.
96. Noris, M and Ruggenenti, P and Perna, A and (1999) Hypocomplementemia discloses genetic predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: Role of factor H abnormalities J Am Soc Nephrol, 10, pp. 281-293. Italian Registry of Familial and Recurrent Hemolytic Uremic Syndrome/Thrombotic Thrombocytopenic Purpura
97. Ohali, M and Shalev, H and Schlesinger, M and (1998) Hypocomplementemic autosomal recessive hemolytic uremic syndrome with decreased factor H Pediatr Nephrol, 12, pp. 619-624.
98. Rougier, N and Kazatchkine, MD and Rougier, JP and (1998) Human complement factor H deficiency associated with hemolytic uremic syndrome J Am Soc Nephrol, 9, pp. 2318-2326.
99. Zipfel, PF. (2001) Hemolytic uremic syndrome: How do factor H mutants mediate endothelial damage? Trends Immunol, 22, pp. 345-348.
100. Rubinstein, MA and Kagan, BM and MacGillviray, MH and Merliss, R and Sacks, H. (1959) Unusual remission in a case of thrombotic thrombocytopenic purpura syndrome following fresh blood exchange Ann Int Med, 51, pp. 1409-1419.
101. Byrnes, JJ and Khurana, M. (1977) Treatment of thrombotic thrombocytopenic purpura with plasma N Engl J Med, 297, pp. 1386-1389.
102. Moake, JL and Byrnes, JJ and Troll, JH and (1985) Effects of fresh-frozen plasma and its cryosupernatant fraction on von Willebrand factor multimeric forms in chronic relapsing thrombotic thrombocytopenic purpura Blood, 65, pp. 1232-1236.
103. Shepard, KV and Bukowski, RM. (1987) The treatment of thrombotic thrombocytopenic purpura with exchange transfusions, plasma infusions, and plasma exchange Semin Hematol, 24, pp. 178-193.
104. Kwaan, HC and Soff, GA. (1997) Management of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome Semin Hematol, 34, pp. 159-166.
105. Hayward, CP and Sutton, DM and Carter, WH, Jr. and (1994) Treatment outcomes in patients with adult thrombotic thrombocytopenic purpura-hemolytic uremic syndrome Arch Int Med, 154, pp. 982-987.
106. Pisciotta, AV and Garthwaite, T and Darin, J and Aster, RH. (1977) Treatment of thrombotic thrombocytopenic purpura by exchange transfusion Am J Hematol, 3, pp. 73-82.
107. Roberts, AW and Gillett, EA and Fleming, SJ. (1991) Hemolytic uremic syndrome/thrombotic thrombocytopenic purpura: Outcome with plasma exchange J Clin Apheresis, 6, pp. 150-154.
108. Rock, G and Shumak, K and Kelton, J and (1992) Canadian Apheresis Study Group: Thrombotic thrombocytopenic purpura: Outcome in 24 patients with renal impairment treated with plasma exchange Transfusion, 32, pp. 710-714.
109. Fontana, S and Hovinga, JA and Studt, JD and Alberio, L and Lämmle, B and Taleghani, BM. (2004) Plasma therapy in thrombotic thrombocytopenic purpura: Review of the literature and the Bern experience in a subgroup of patients with severe acquired ADAMTS-13 deficiency Semin Hematol, 41, pp. 48-59.
110. Coppo, P and Bussel, A and Charrier, S and (2003) High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome Medicine (Baltimore), 82, pp. 27-38.
111. Rock, GA and Shumak, KH and Buskard, NA and (1991) Canadian Apheresis Study Group: Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura N Engl J Med, 325, pp. 393-397.
112. Sadler, JE and Moake, JL and Miyata, T and George, JN. (2004) Recent advances in thrombotic thrombocytopenic purpura Hematology (Am Soc Hematol Educ Program), pp. 407-423.
113. Zheng, XL and Kaufman, RM and Goodnough, LT and Sadler, JE. (2004) Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura Blood, 103, pp. 4043-4049.
114. de la Rubia, J and Lopez, A and Arriaga, F and (1999) Response to plasma exchange and steroids as combined therapy for patients with thrombotic thrombocytopenic purpura Acta Haematol, 102, pp. 12-16.
115. Dervenoulas, J and Tsirigotis, P and Bollas, G and (2001) Efficacy of intravenous immunoglobulin in the treatment of thrombotic thrombocytopaenic purpura. A study of 44 cases Acta Haematol, 105, pp. 204-208.
116. Zappasodi, P and Corso, A and Castagnola, C and Tajana, M and Lunghi, M and Bernasconi, C. (1999) A successful combination of plasma exchange and intravenous cyclophosphamide in a patient with a refractory thrombotic thrombocytopenic purpura Eur J Haematol, 63, pp. 278-279.
117. Moake, JL and Rudy, CK and Troll, JH and (1985) Therapy of chronic relapsing thrombotic thrombocytopenic purpura with prednisone and azathioprine Am J Hematol, 20, pp. 73-79.
118. Yomtovian, R and Niklinski, W and Silver, B and Sarode, R and Tsai, HM. (2004) Rituximab for chronic recurring thrombotic thrombocytopenic purpura: A case report and review of the literature Br J Haematol, 124, pp. 787-795.
119. Ahmad, A and Aggarwal, A and Sharma, D and (2004) Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP) Am J Hematol, 77, pp. 171-176.
120. Kremer Hovinga, JA and Studt, JD and Demarmels Biasiutti, F. (2004) Splenectomy in relapsing and plasma-refractory acquired thrombotic thrombocytopenic purpura Haematologica, 89, pp. 320-324.
121. Gaddis, TG and Guthrie, TH, Jr and Drew, MJ and Sahud, M and Howe, RB and Mittelman, A. (1997) Treatment of plasma refractory thrombotic thrombocytopenic purpura with protein A immunoabsorption Am J Hematol, 55, pp. 55-58.
122. Gutterman, LA and Stevenson, TD. (1982) Treatment of thrombotic thrombocytopenic purpura with vincristine JAMA, 247, pp. 1433-1436.
123. Ferrara, F and Annunziata, M and Pollio, F and (2002) Vincristine as treatment for recurrent episodes of thrombotic thrombocytopenic purpura Ann Hematol, 81, pp. 7-10.
124. Plaimauer, B and Zimmermann, K and Volkel, D and (2002) Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13) Blood, 100, pp. 3626-3632.
125. Plaimauer, B and Scheiflinger, F. (2004) Expression and characterization of recombinant human ADAMTS-13 Semin Hematol, 41, pp. 24-33.
126. Remuzzi, G and Ruggenenti, P. (1995) The hemolytic uremic syndrome Kidney Int, 47, pp. 2-19.
127. Wong, CS and Jelacic, S and Habeeb, RL and Watkins, SL and Tarr, PI. (2000) The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections N Engl J Med, 342, pp. 1930-1936.
128. Byun, Y and Ohmura, M and Fujihashi, K and (2001) Nasal immunization with E. coli verotoxin 1 (VT1)-B subunit and a nontoxic mutant of cholera toxin elicits serum neutralizing antibodies Vaccine, 19, pp. 2061-2070.
129. Misiani, R and Appiani, AC and Edefonti, A and (1982) Haemolytic uraemic syndrome: Therapeutic effect of plasma infusion Br Med J, 285, pp. 1304-1306.
130. Sheth, KJ and Gill, JC and Hanna, J and Leichter, HE. (1988-89) Failure of fresh frozen plasma infusions to alter the course of hemolytic uremic syndrome Child Nephrol Urol, 9, pp. 38-41.
131. Loirat, C and Sonsino, E and Hinglais, N and Jais, JP and Landais, P and Fermanian, J. (1988) Treatment of the childhood haemolytic uraemic syndrome with plasma Pediatr Nephrol, 2, pp. 279-285. A multicentre randomized controlled trial. The French Society of Paediatric Nephrology
132. Rizzoni, G and Claris-Appiani, A and Edefonti, A and (1988) Plasma infusion for hemolytic-uremic syndrome in children: Results of a multicenter controlled trial J Pediatr, 112, pp. 284-290.
133. Dundas, S and Murphy, J and Soutar, RL and Jones, GA and Hutchinson, SJ and Todd, WT. (1999) Effectiveness of therapeutic plasma exchange in the 1996 Lanarkshire Escherichia coli O157:H7 outbreak Lancet, 354, pp. 1327-1330.